The Department of Pharmaceutical Chemistry at the University of Basrah's College of Pharmacy organized a scientific seminar titled: "Design, Synthesis, and Characterization of New Thiazolidine-2,4-dione Derivatives as Anti-diabetic Agents."
Synthesis & Methodology
Assistant Lecturer **Rawnaq Thamir Kadhim** presented an innovative three-stage synthetic pathway involving thiourea, chloroacetic acid, and vanillin to produce seven novel Thiazolidine derivatives. These compounds were rigorously characterized using physical analysis and state-of-the-art spectroscopic techniques.
Biological Evaluation & Comparative Results
Test Models
Evaluated on sucrose-loaded healthy rats and Streptozotocin-induced diabetic rat models.
Efficacy Outcome
Significant reduction in blood glucose levels was observed across all tested derivatives.
Clinical Advantage
Newly synthesized derivatives demonstrated therapeutic potency exceeding that of standard pharmaceutical drugs used in the study.
This research effort marks a significant advancement in local pharmaceutical innovation, offering potential new avenues for cost-effective diabetes management. The study emphasizes the College of Pharmacy's commitment to translating bench-side chemistry into possible clinical solutions.
